These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32396423)

  • 1. Re: Long-Term Survival after Percutaneous Radiofrequency Ablation of Pathologically Proven Renal Cell Carcinoma in 100 Patients.
    Cadeddu JA
    J Urol; 2020 Aug; 204(2):366. PubMed ID: 32396423
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma.
    Laguna MP
    J Urol; 2013 Oct; 190(4):1205-6. PubMed ID: 24029306
    [No Abstract]   [Full Text] [Related]  

  • 3. Percutaneous ultrasound-guided radiofrequency ablation of recurrent renal cell carcinoma in renal allograft after partial nephrectomy.
    Goeman L; Joniau S; Oyen R; Van Poppel H
    Urology; 2006 Jan; 67(1):199. PubMed ID: 16413367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intermediate outcomes and predictors of efficacy in the radiofrequency ablation of 100 pathologically proven renal cell carcinomas.
    McClure TD; Chow DS; Tan N; Sayre JA; Pantuck AJ; Raman SS
    J Vasc Interv Radiol; 2014 Nov; 25(11):1682-8; quiz 1689. PubMed ID: 25081202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Radiofrequency ablation of renal cell carcinoma].
    Estebanez Zarranz J; Artozki Morras E; Aguirreazaldegui García L; Crespo Crespo I; Bandres Iruretagoyena F; Sanz Jaka JP
    Actas Urol Esp; 2009 May; 33(5):514-21. PubMed ID: 19658304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How I do it: percutaneous radiofrequency ablation (RFA).
    Sorokin I; Chamarthy M; Cadeddu JA
    Can J Urol; 2017 Feb; 24(1):8679-8683. PubMed ID: 28263138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer-free survival and local tumor control after impendence-based radiofrequency ablation of biopsy-proven renal cell carcinomas with a minimum of 1-year follow-up.
    Forauer AR; Dewey BJ; Seigne JD
    Urol Oncol; 2014 Aug; 32(6):869-76. PubMed ID: 24946958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous Thermal Ablation for Treatment of T1a Renal Cell Carcinomas.
    Shakeri S; Raman SS
    Radiol Clin North Am; 2020 Sep; 58(5):981-993. PubMed ID: 32792128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiofrequency ablation of renal cell carcinoma with pathological correlation.
    Fotiadis N; Matson M
    Br J Radiol; 2009 Jan; 82(973):83; author reply 83-4. PubMed ID: 19095820
    [No Abstract]   [Full Text] [Related]  

  • 10. Re: Oncologic Outcomes following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.
    Cadeddu JA
    J Urol; 2020 Jan; 203(1):28. PubMed ID: 31618160
    [No Abstract]   [Full Text] [Related]  

  • 11. Re: Oncologic Outcomes following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.
    Laguna MP
    J Urol; 2020 Jan; 203(1):27-28. PubMed ID: 31618159
    [No Abstract]   [Full Text] [Related]  

  • 12. [Radiofrequency ablation of renal cell carcinoma].
    Estébanez Zarranz J; Artozki Morras E; Aguirreazaldegui García L; Crespo Crespo I; Bandrés Iruretagoyena F; Sanz Jaka JP
    Actas Urol Esp; 2009 Jan; 33(1):35-42. PubMed ID: 19462723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous transthoracic radiofrequency ablation of renal tumors using an iatrogenic pneumothorax.
    Ahrar K; Matin S; Wallace MJ; Gupta S; Hicks ME
    AJR Am J Roentgenol; 2005 Jul; 185(1):86-8. PubMed ID: 15972404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Image-guided radiofrequency ablation of renal cell carcinoma.
    Boss A; Clasen S; Kuczyk M; Schick F; Pereira PL
    Eur Radiol; 2007 Mar; 17(3):725-33. PubMed ID: 17021704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous imaging-guided radiofrequency ablation of small renal cell carcinoma: techniques and outcomes of 24 treatment sessions in 18 consecutive patients.
    Popovic P; Surlan-Popovic K; Lukic S; Mijailovic M; Jankovic S; Kuhelj D
    J BUON; 2011; 16(1):127-32. PubMed ID: 21674863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of CT during renal arteriography: a case of percutaneous radiofrequency ablation for renal cell carcinoma.
    Tanigawa N; Kariya S; Komemushi A; Kojima H; Sawada S
    Cardiovasc Intervent Radiol; 2004; 27(6):669-70. PubMed ID: 15593433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined MRI and fluoroscopic guided radiofrequency ablation of a renal tumor.
    Fotiadis NI; Sabharwal T; Gangi A; Adam A
    Cardiovasc Intervent Radiol; 2009 Jan; 32(1):184-7. PubMed ID: 18392889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of transhepatic radiofrequency ablation of renal cell carcinoma.
    McGahan JP; Ro KM; Evans CP; Ellison LM
    AJR Am J Roentgenol; 2006 May; 186(5 Suppl):S311-5. PubMed ID: 16632693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Survival after Percutaneous Radiofrequency Ablation of Pathologically Proven Renal Cell Carcinoma in 100 Patients.
    Marshall HR; Shakeri S; Hosseiny M; Sisk A; Sayre J; Lu DS; Pantuck A; Raman S
    J Vasc Interv Radiol; 2020 Jan; 31(1):15-24. PubMed ID: 31767409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contemporary Status of Percutaneous Ablation for the Small Renal Mass.
    Shin BJ; Chick JF; Stavropoulos SW
    Curr Urol Rep; 2016 Mar; 17(3):23. PubMed ID: 26874535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.